Rivus Pharmaceuticals

About:

Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.

Website: https://www.rivuspharma.com

Twitter/X: rivuspharma

Top Investors: RA Capital Management, Longitude Capital, Medicxi, Bain Capital Life Sciences, BB Biotech Ventures

Description:

Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health. Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity.

Total Funding Amount:

$167M

Headquarters Location:

Charlottesville, Virginia, United States

Founded Date:

2019-01-01

Founders:

Allen Cunningham

Number of Employees:

11-50

Last Funding Date:

2022-09-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai